Trending News

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025
Posted On Friday, February 14, 2025
Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
Posted On Friday, February 14, 2025
Apellis Pharmaceuticals to Host Conference Call on February 28, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
Posted On Friday, February 14, 2025
Volta Medical Artificial Intelligence-guided Cardiac Ablation Procedure Improves Treatment of Atrial Fibrillation
Posted On Friday, February 14, 2025
Nxera Pharma Proposes Changes to its Board of Directors
Posted On Friday, February 14, 2025
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2024
Posted On Friday, February 14, 2025
Theratechnologies Resumes Distribution of EGRIFTA SV®
Posted On Thursday, February 13, 2025
Peptone Market to Reach $240.5 million, Globally, by 2035 at 4.2% CAGR: Allied Market Research
Posted On Thursday, February 13, 2025
Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
Posted On Thursday, February 13, 2025
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
Posted On Thursday, February 13, 2025
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
Posted On Thursday, February 13, 2025
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Posted On Thursday, February 13, 2025
Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology
Posted On Thursday, February 13, 2025
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
Posted On Thursday, February 13, 2025
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Posted On Thursday, February 13, 2025
Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference
Posted On Thursday, February 13, 2025
Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Posted On Thursday, February 13, 2025
PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Posted On Thursday, February 13, 2025
Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th
Posted On Thursday, February 13, 2025
Bio-Path Holdings Expands Global Patent Portfolio
Posted On Thursday, February 13, 2025
BridgeBio Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on February 20, 2025
Posted On Thursday, February 13, 2025
Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
Posted On Thursday, February 13, 2025
The Shift Towards Proactive Health: Biologic Pharmamedical Stands Firm Amidst Tariffs and Big Pharma Shakeup
Posted On Thursday, February 13, 2025
LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Posted On Thursday, February 13, 2025
Medicenna Reports Third Quarter Fiscal 2025 Financial and Operational Results and Provides Anticipated Milestones
Posted On Thursday, February 13, 2025

Print